Jerry Roy, MD
Interventional Cardiology · Bowling Green, KYNPI 1487826814
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 435 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,011 and has fallen 58.8% since, to $829 in 2025. That places this record below the midpoint for interventional cardiology clinicians in KY, where the typical reported total is $7,951.
Across 435 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Novartis$1K
- Johnson & Johnson$827
- Pfizer$671
- Amgen$322
- AstraZeneca$321
- plus $3K from 30 others
Across 10 payments — averaging $17,219 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$135K
- Amgen$37K
What the payments were for
- Travel & lodging$3194%
- Food & beverage$7,81196%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 60 | $1,622 |
| Novartis | 83 | $1,297 |
| Johnson & Johnson | 67 | $827 |
| Pfizer | 45 | $671 |
| Amgen | 20 | $322 |
| AstraZeneca | 15 | $321 |
| Abiomed | 9 | $306 |
| Boehringer Ingelheim | 17 | $282 |
| Boston Scientific | 9 | $271 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $221 |
| Sanofi-aventis U.S. LLC | 11 | $199 |
| Abbott | 5 | $191 |
| Novo Nordisk | 9 | $185 |
| Merck | 12 | $178 |
| Actelion Pharmaceuticals US, Inc. | 8 | $162 |
| Siemens Medical Solutions USA, Inc. | 1 | $161 |
| Inari Medical, Inc. | 4 | $131 |
| E.r. Squibb & Sons, L.L.C. | 6 | $99 |
| Amarin Pharma, Inc. | 6 | $98 |
| Chiesi USA, Inc. | 4 | $76 |
| Edwards Lifesciences | 2 | $60 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| Lundbeck LLC | 4 | $56 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Terumo Medical Corporation | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Bayer | 2 | $26 |
| Merge Healthcare Incorporated | 1 | $23 |
| Biotronik Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Angiodynamics, Inc. | 1 | $15 |
| Braemar Manufacturing, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$319
- COREVALVE EVOLUT R$186
- Biograph Horizon-3R$161
- Impella$146
- BRILINTA$113
- MitraClip$111
- ENTRESTO$108
How this compares
$8,145 in reported general payments places this provider in the 50th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 324 | $311,592 |
| BrilintaTicagrelor | 72 | $42,251 |
| XareltoRivaroxaban | 36 | $41,702 |
| EntrestoSacubitril/Valsartan | 37 | $28,750 |
| JardianceEmpagliflozin | 26 | $17,232 |
| MultaqDronedarone Hcl | 19 | $16,769 |
| Repatha SureclickEvolocumab | 23 | $13,999 |
| Ranolazine ErRanolazine | 62 | $3,431 |
| Metoprolol Succinate | 283 | $2,735 |
| Amiodarone Hcl | 59 | $1,958 |
| Atorvastatin Calcium | 189 | $1,306 |
| Nifedipine ErNifedipine | 67 | $1,013 |
| Metoprolol Tartrate | 213 | $1,011 |
| ClopidogrelClopidogrel Bisulfate | 107 | $920 |
| Lisinopril | 126 | $752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $671 | $311,592324 claims |
| AstraZenecaBrilinta | $321 | $42,25172 claims |
| Johnson & JohnsonXarelto | $827 | $41,70236 claims |
| NovartisEntresto | $1,297 | $28,75037 claims |
| Boehringer IngelheimJardiance | $282 | $17,23226 claims |
| Sanofi-aventis U.S. LLCMultaq | $199 | $16,76919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 129 interventional cardiology providers in Kentucky.
Other interventional cardiology in Bowling Green
- Rahil RafeedheenBowling Green$31K
- Sandeep ChhabraBowling Green$18K
- Mohammed KazimuddinBowling Green$17K
- Mohammad Abdul WaheedBowling Green$10K
- Amit SrivastavaEdgewood$642K
- Avichai EresLexington$616K
- Steve LinLexington$362K
- Daniel StewartLouisville$290K
- Robert SawyerLexington$249K
- Ganesh Keshav ThirunavukkarasuLexington$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.